Nurix says protein degrader shows potential in Waldenstrom’s patients in early trial

Nurix Therapeutics’ BTK degrader has elicited responses in a small group of patients with certain cancers, supporting the biotech’s claim that the drug could potentially …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

FDA Warns of Overdoses With Compounded Semaglutide

Overdoses, some even requiring hospitalization, have occurred due to patient and physician confusion around compounded semaglutide, the FDA detailed in an alert. Adverse events reported

July 30, 2024

Cannabist Q3 Was Flat Sequentially

The Cannabist Company Reports Third Quarter 2023 Results NEW YORK–(BUSINESS WIRE)–The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or

November 14, 2023

Closed Loop Medicine appoints Kate Woolland as Chief Operating Officer

The key executive appointment supports the strategic, operational delivery of the Company’s product and partnership programs.

June 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.